BiotechEast Co., Ltd. is pleased to announce its new position as the Taiwan arm of BIO•sin•thesys.
The BIO•sin•thesys network, a branch of Philadelphia-based GC3 Strategy LLC Global Solutions Consultants, connects the premiere US cluster for biotechnology development in the US Mid-Atlantic with dynamic, emerging biotechnology markets of Asia.
|M.T. ("Terry") Cooke is the Founder and Chief Executive Officer of GC3 Strategy LLC. He started GC3 to advance an extraordinary global economic opportunity: to catalyze in US and European businesses and organizations the know how to work more effectively and strategically with emerging Asian economies.
During Terry's 15 year career with the US Foreign Commercial Service, he held progressively more responsible positions at the US Missions in Asia (Taipei, Tokyo, Shanghai) and Europe (Berlin) acting as the US Government's senior commercial representative in Taiwan and Berlin. These responsibilities enabled Terry to build strong commercial relationships that are now solidified to direct his company's network plant and initiatives. His consensus building skills, capacity for cross-cultural bridge building, mastery of languages and cultural norms and his personal dedication to the cause of win-win industrial strategies between east and west, make Terry a leader to connect the USA and Europe with the large, fast paced Asian economies that makes the new single global economy a reality.
In addition to his Foreign Service career, Dr. Cooke has been a Senior Fellow at the Foreign Policy Research Institute in Philadelphia and a senior consultant to the RAND Corporation. He currently advises the Lauder Institute at the University of Pennsylvania Wharton School and the City of Philadelphia on its global business outreach initiatives.
He is a graduate of U.C. Berkeley--Ph.D. (1985) and M.A. (1981)--and Princeton University--B.A. (1976).
• Regional base for biotechs (E&Y Global Biotech Report 2005)
• Home to 90% of US pharmaceutical market (southern NJ/southeastern PA)
• N.I.H., the world's largest funder of biotechnology innovation (Bethesda, MD)
• Access to New York capital markets & mid-Atlantic venture funds (NYC, etc)
• Nation's 'foundation legacy' for healthcare education/delivery (Philadelphia)
• Premier educational hotbeds for innovation (Princeton, UPenn, JHU, etc)
Asia's Emerging Biotech Markets:
• 'The Nimble Three':
• 'Tomorrow's Giants':
The BIO•sin•thesys Global Resource Network has its own experts in place in Philadelphia, New York and Washington DC for the US Mid-Atlantic and in eleven strategic locations in Asia (HK, Singapore, Taipei [BiotechEast Co., Ltd.], Beijing/Tianjin, Shanghai/Nanjing, Shenzhen, Chongqing/Xian, New Delhi, Bombay, Bangalore/Kerala and Calcutta)
GC3's BIO•sin•thesys network offers a bi-directional array of customized services for bridging the US Mid-Atlantic and Asia.
GC3's BIO•sin•thesys network can help convert your company/organization's investment in global outreach into a low-cost/high-return program of reliable execution and delivery.
BIO•sin•thesys promises to deliver as your 'partner without peer' based on GC3 Strategy's unique value proposition of top-tier talent, low-cost infrastructure in key markets, and unrivalled global connectivity and insight.
For more information, please contact:
BiotechEast Co., Ltd.
Or contact the consultants at BIO•sin•thesys at:
Or contact GC3 Strategy LLC at: